-
1دورية أكاديمية
المؤلفون: Yi, TW, Smyth, B, Di Tanna, GL, Arnott, C, Cardoza, K, Kang, A, Pollock, C, Agarwal, R, Bakris, G, Charytan, DM, de Zeeuw, D, Heerspink, HJL, Neal, B, Wheeler, DC, Cannon, CP, Zhang, H, Zinman, B, Perkovic, V, Levin, A, Mahaffey, KW, Jardine, M, Brenner, BM, Greene, T, Jardine, MJ, Meininger, G, Li, N, Kolesnyk, I, Aizenberg, D, Pecoits-Filho, R, Cherney, D, Obrador, G, Chertow, G, Chang, T, Hawley, C, Ji, L, Wada, T, Jha, V, Lim, SK, Lim-Abrahan, MA, Santos, F, Chae, DW, Hwang, SJ, Vazelov, E, Rychlík, I, Hadjadj, S, Krane, V, Rosivall, L, De Nicola, L, Dreval, A, Nowicki, M, Schiller, A, Distiller, L, Górriz, JL, Kolesnyk, M, David, Wheeler, C, Guerrero, RAA, Albisu, JP, Alvarisqueta, A, Bartolacci, I, Berli, MA, Bordonava, A, Calella, P, Cantero, MC, Cartasegna, LR, Cercos, E, Coloma, GC, Colombo, H, Commendatore, V, Cuadrado, J, Cuneo, CA, Cusumano, AM, Douthat, WG, Dran, RD, Farias, E, Fernandez, MF, Finkelstein, H, Fragale, G, Fretes, JO, Garcia, NH, Gastaldi, A, Gelersztein, E, Glenny, JA, Gonzalez, JP, Colaso, PDCG, Goycoa, C, Greloni, GC, Guinsburg, A, Hermida, S, Juncos, LI, Klyver, MI, Kraft, F, Krynski, F, Lanchiotti, PV, Leon de la Fuente, RA, Marchetta, N, Mele, P, Nicolai, S, Novoa, PA, Orio, SI
المصدر: urn:ISSN:0272-6386 ; urn:ISSN:1523-6838 ; American Journal of Kidney Diseases, 82, 1, 84-96.e1
مصطلحات موضوعية: Clinical Trials and Supportive Activities, Clinical Research, Kidney Disease, Prevention, Cardiovascular, 6 Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Renal and urogenital, 3 Good Health and Well Being, Male, Female, Humans, Middle Aged, Aged, Canagliflozin, Diabetic Nephropathies, Sodium-Glucose Transporter 2 Inhibitors, Creatinine, Diabetes Mellitus, Type 2, Treatment Outcome, Kidney, Cardiovascular Diseases, Renal Insufficiency, Diabetic kidney disease, age, cardiovascular outcomes, chronic kidney disease, diabetes, kidney outcomes
العلاقة: http://hdl.handle.net/1959.4/unsworks_84366Test; https://doi.org/10.1053/j.ajkd.2022.12.015Test
الإتاحة: https://doi.org/10.1053/j.ajkd.2022.12.015Test
http://hdl.handle.net/1959.4/unsworks_84366Test -
2دورية أكاديمية
المؤلفون: Li, JW, Arnott, C, Heerspink, HJL, Mbiostat, QL, Cannon, CP, Wheeler, DC, Charytan, DM, Barraclough, J, Figtree, GA, Agarwal, R, Bakris, G, de Zeeuw, D, Greene, T, Levin, A, Pollock, C, Zhang, H, Zinman, B, Mahaffey, KW, Perkovic, V, Neal, B, Jardine, MJ
المصدر: urn:ISSN:2047-9980 ; Journal of the American Heart Association, 11, 16, e025045
مصطلحات موضوعية: Diabetes, Heart Disease, Clinical Research, Kidney Disease, Prevention, Clinical Trials and Supportive Activities, Cardiovascular, Renal and urogenital, 3 Good Health and Well Being, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, chronic kidney disease, recurrent cardiovascular event, anzsrc-for: 1102 Cardiorespiratory Medicine and Haematology
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_82217Test; https://unsworks.unsw.edu.au/bitstreams/b7f966ad-e35a-43d8-9440-5c33f9417488/downloadTest; https://doi.org/10.1161/JAHA.121.025045Test
الإتاحة: https://doi.org/10.1161/JAHA.121.025045Test
http://hdl.handle.net/1959.4/unsworks_82217Test
https://unsworks.unsw.edu.au/bitstreams/b7f966ad-e35a-43d8-9440-5c33f9417488/downloadTest -
3دورية أكاديمية
المؤلفون: Sarraju, A, Bakris, G, Cannon, CP, Cherney, D, Damaraju, CV, Figtree, GA, Gogate, J, Greene, T, Heerspink, HJL, Januzzi, JL, Neal, B, Jardine, MJ, Blais, J, Kosiborod, M, Levin, A, Lingvay, I, Weir, MR, Perkovic, V, Mahaffey, KW
المصدر: urn:ISSN:0735-1097 ; urn:ISSN:1558-3597 ; Journal of the American College of Cardiology, 80, 18, 1721-1731
مصطلحات موضوعية: Cardiovascular, Diabetes, Kidney Disease, Clinical Research, Renal and urogenital, Metabolic and endocrine, 3 Good Health and Well Being, Adult, Female, Humans, Male, Middle Aged, Albuminuria, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Glomerular Filtration Rate, Heart Failure, Kidney, Sodium-Glucose Transporter 2 Inhibitors, SGLT2 inhibitor, cardiovascular outcomes, anzsrc-for: 1102 Cardiorespiratory Medicine and Haematology, anzsrc-for: 1117 Public Health and Health Services
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_84912Test; https://unsworks.unsw.edu.au/bitstreams/cb9b8743-c408-4739-bcf8-fde13c89ee3b/downloadTest; https://doi.org/10.1016/j.jacc.2022.08.772Test
الإتاحة: https://doi.org/10.1016/j.jacc.2022.08.772Test
http://hdl.handle.net/1959.4/unsworks_84912Test
https://unsworks.unsw.edu.au/bitstreams/cb9b8743-c408-4739-bcf8-fde13c89ee3b/downloadTest -
4دورية أكاديمية
المؤلفون: Barraclough, JY, Yu, J, Figtree, GA, Perkovic, V, Heerspink, HJL, Neuen, BL, Cannon, CP, Mahaffey, KW, Schutte, AE, Neal, B, Arnott, C
المصدر: urn:ISSN:1462-8902 ; urn:ISSN:1463-1326 ; Diabetes, Obesity and Metabolism, 24, 6, 1072-1083
مصطلحات موضوعية: Clinical Research, Cardiovascular, Kidney Disease, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, 3 Good Health and Well Being, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Kidney Diseases, Peripheral Arterial Disease, Sodium-Glucose Transporter 2 Inhibitors, antidiabetic drug, cardiovascular disease, clinical trial, anzsrc-for: 1103 Clinical Sciences
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_85170Test; https://unsworks.unsw.edu.au/bitstreams/7e1d9c57-b7a8-46d6-aac7-4910e4ad2fd9/downloadTest; https://doi.org/10.1111/dom.14671Test
الإتاحة: https://doi.org/10.1111/dom.14671Test
http://hdl.handle.net/1959.4/unsworks_85170Test
https://unsworks.unsw.edu.au/bitstreams/7e1d9c57-b7a8-46d6-aac7-4910e4ad2fd9/downloadTest -
5دورية أكاديمية
المؤلفون: Jardine, M, Zhou, Z, Lambers Heerspink, HJ, Hockham, C, Li, Q, Agarwal, R, Bakris, GL, Cannon, CP, Charytan, DM, Greene, T, Levin, A, Li, JW, Neuen, BL, Neal, B, Oh, R, Oshima, M, Pollock, C, Wheeler, DC, de Zeeuw, D, Zhang, H, Zinman, B, Mahaffey, KW, Perkovic, V
المصدر: urn:ISSN:1555-9041 ; urn:ISSN:1555-905X ; Clinical Journal of the American Society of Nephrology, 16, 3, 384-395
مصطلحات موضوعية: Clinical Research, Kidney Disease, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, Renal and urogenital, 3 Good Health and Well Being, Aged, Albuminuria, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Humans, Kidney Diseases, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, SGLT2 inhibitors, cardiovascular system, chronic kidney disease progression, diabetes, randomized controlled trials, anzsrc-for: 1103 Clinical Sciences
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_76557Test; https://unsworks.unsw.edu.au/bitstreams/cd82ab40-5a1f-4021-8ee7-b54e8cb2ce35/downloadTest; https://doi.org/10.2215/CJN.15260920Test
الإتاحة: https://doi.org/10.2215/CJN.15260920Test
http://hdl.handle.net/1959.4/unsworks_76557Test
https://unsworks.unsw.edu.au/bitstreams/cd82ab40-5a1f-4021-8ee7-b54e8cb2ce35/downloadTest -
6دورية أكاديمية
المؤلفون: Sarraju, A, Li, JW, Cannon, CP, Chang, TI, Agarwal, R, Bakris, G, Charytan, DM, de Zeeuw, D, Greene, T, Heerspink, HJL, Levin, A, Neal, B, Pollock, C, Wheeler, DC, Yavin, Y, Zhang, H, Zinman, B, Perkovic, V, Jardine, M, Mahaffey, KW
المصدر: urn:ISSN:0002-8703 ; urn:ISSN:1097-6744 ; American Heart Journal, 233, 141-148
مصطلحات موضوعية: Aging, Clinical Research, Cardiovascular, Kidney Disease, Heart Disease, Clinical Trials and Supportive Activities, Diabetes, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, Renal and urogenital, Metabolic and endocrine, Adrenergic beta-Antagonists, Age Factors, Aged, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diuretics, Double-Blind Method, Female, Heart Failure, Humans, Male, Middle Aged, Placebos, Renal Insufficiency, Chronic, Sex Factors, Sodium-Glucose Transporter 2 Inhibitors
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_76537Test; https://unsworks.unsw.edu.au/bitstreams/5eb3b99d-1713-4bd4-9aa5-019a08d671c1/downloadTest; https://doi.org/10.1016/j.ahj.2020.12.008Test
الإتاحة: https://doi.org/10.1016/j.ahj.2020.12.008Test
http://hdl.handle.net/1959.4/unsworks_76537Test
https://unsworks.unsw.edu.au/bitstreams/5eb3b99d-1713-4bd4-9aa5-019a08d671c1/downloadTest -
7دورية أكاديمية
المؤلفون: Arnott, C, Li, Q, Kang, A, Neuen, BL, Bompoint, S, Lam, CSP, Rodgers, A, Mahaffey, KW, Cannon, CP, Perkovic, V, Jardine, MJ, Neal, B
المصدر: urn:ISSN:2047-9980 ; Journal of the American Heart Association, 9, 3, e014908
مصطلحات موضوعية: Kidney Disease, Diabetes, Heart Disease, Cardiovascular, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, 3 Good Health and Well Being, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Heart Disease Risk Factors, Humans, Male, Middle Aged, Protective Factors, Randomized Controlled Trials as Topic, Risk Assessment, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, cardiovascular disease, meta‐analysis, sodium‐glucose cotransporter 2 inhibition, type 2 diabetes mellitus, anzsrc-for: 1102 Cardiorespiratory Medicine and Haematology
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_66622Test; https://unsworks.unsw.edu.au/bitstreams/62012fe4-bf0b-45aa-b2b5-3c06ab5bb6ae/downloadTest; https://doi.org/10.1161/JAHA.119.014908Test
الإتاحة: https://doi.org/10.1161/JAHA.119.014908Test
http://hdl.handle.net/1959.4/unsworks_66622Test
https://unsworks.unsw.edu.au/bitstreams/62012fe4-bf0b-45aa-b2b5-3c06ab5bb6ae/downloadTest -
8دورية أكاديمية
المؤلفون: Jardine, MJ, Zhou, Z, Mahaffey, KW, Oshima, M, Agarwal, R, Bakris, G, Bajaj, HS, Bull, S, Cannon, CP, Charytan, DM, De Zeeuw, D, Di Tanna, GL, Greene, T, Heerspink, HJL, Levin, A, Neal, B, Pollock, C, Qiu, R, Sun, T, Wheeler, DC, Zhang, H, Zinman, B, Rosenthal, N, Perkovic, V
المصدر: urn:ISSN:1046-6673 ; urn:ISSN:1533-3450 ; Journal of the American Society of Nephrology, 31, 5, 1128-1139
مصطلحات موضوعية: Clinical Trials and Supportive Activities, Kidney Disease, Clinical Research, Prevention, 6 Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Renal and urogenital, Adult, Aged, Albuminuria, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Double-Blind Method, Female, Humans, Kidney, Kidney Tubules, Proximal, Male, Middle Aged, Risk, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, SGLT2 inhibitor, chronic kidney disease, diabetes, end-stage kidney disease
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_69269Test; https://unsworks.unsw.edu.au/bitstreams/c0db0fb7-0d50-45b5-8a35-53eab39b7e09/downloadTest; https://doi.org/10.1681/ASN.2019111168Test
الإتاحة: https://doi.org/10.1681/ASN.2019111168Test
http://hdl.handle.net/1959.4/unsworks_69269Test
https://unsworks.unsw.edu.au/bitstreams/c0db0fb7-0d50-45b5-8a35-53eab39b7e09/downloadTest -
9دورية أكاديمية
المؤلفون: Arnott, C, Neuen, BL, Heerspink, HJL, Figtree, GA, Kosiborod, M, Lam, CS, Cannon, CP, Rosenthal, N, Shaw, W, Mahaffey, KW, Jardine, MJ, Perkovic, V, Neal, B
المصدر: urn:ISSN:0167-5273 ; urn:ISSN:1874-1754 ; International Journal of Cardiology, 318, 126-129
مصطلحات موضوعية: Nutrition, Clinical Trials and Supportive Activities, Prevention, Cardiovascular, Diabetes, Heart Disease, Clinical Research, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, Metabolic and endocrine, 3 Good Health and Well Being, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor, Heart Disease Risk Factors, Humans, Hypoglycemic Agents, Risk Factors, Cardiovascular disease, type 2 diabetes, GLP1 receptor agonist, SGLT2 inhibition, anzsrc-for: 1102 Cardiorespiratory Medicine and Haematology, anzsrc-for: 1117 Public Health and Health Services
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_72129Test; https://unsworks.unsw.edu.au/bitstreams/ddb92ba4-055c-488d-b0fd-dbe4a9271f91/downloadTest; https://doi.org/10.1016/j.ijcard.2020.06.011Test
الإتاحة: https://doi.org/10.1016/j.ijcard.2020.06.011Test
http://hdl.handle.net/1959.4/unsworks_72129Test
https://unsworks.unsw.edu.au/bitstreams/ddb92ba4-055c-488d-b0fd-dbe4a9271f91/downloadTest -
10دورية أكاديمية
المؤلفون: Mahaffey, KW, Jardine, MJ, Bompoint, S, Cannon, CP, Neal, B, Heerspink, HJL, Charytan, DM, Edwards, R, Agarwal, R, Bakris, G, Bull, S, Capuano, G, De Zeeuw, D, Greene, T, Levin, A, Pollock, C, Sun, T, Wheeler, DC, Yavin, Y, Zhang, H, Zinman, B, Rosenthal, N, Brenner, BM, Perkovic, V
المصدر: urn:ISSN:0009-7322 ; urn:ISSN:1524-4539 ; Circulation, 140, 9, 739-750
مصطلحات موضوعية: Clinical Trials and Supportive Activities, Kidney Disease, Prevention, Heart Disease, Clinical Research, Diabetes, Cardiovascular, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, Renal and urogenital, Metabolic and endocrine, 3 Good Health and Well Being, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Humans, Kidney Failure, Chronic, Male, Middle Aged, Placebo Effect, Proportional Hazards Models, Renal Insufficiency, Risk, Secondary Prevention, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/1959.4/unsworks_66375Test; https://unsworks.unsw.edu.au/bitstreams/4904a932-5489-40dc-a0e9-f9b70f47f9b9/downloadTest; https://doi.org/10.1161/CIRCULATIONAHA.119.042007Test
الإتاحة: https://doi.org/10.1161/CIRCULATIONAHA.119.042007Test
http://hdl.handle.net/1959.4/unsworks_66375Test
https://unsworks.unsw.edu.au/bitstreams/4904a932-5489-40dc-a0e9-f9b70f47f9b9/downloadTest
